Certified by Founder Lodge
Attovia Therapeutics
United States - Fremont, California
START UP
1 Disclosed Funding Rounds $105,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Attovia is creating a pipeline of biotherapeutics with an initial focus on immune-mediated disease and oncology. We leverage ATTOBODY, a novel biologics platform, to generate small format bip
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 14 ,2024 | Series B | $105,000,000 | |
| April, 17 ,2025 | Series C | $90,000,000.00 | |
| April, 17 ,2025 | Series C | $90,000,000.00 |
Goldman Sachs
Illumina Ventures
Marshall Wace
Redmile Group
EcoR1 Capital, LLC
Frazier Life Sciences
Nextech Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Allos | $5,000,000 | (Jan 14, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)